This inventor holds 2 USPTO granted patents. Top assignee: Sanofi. Active years: 1995-1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1995-1998
Title: Michel Bonnery: Innovator in Pharmaceutical Chemistry
Introduction
Michel Bonnery is a notable inventor based in Vailhauques, France. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 2 patents. His work focuses on innovative compounds that have potential applications in medicine.
Latest Patents
Bonnery's latest patents include the development of disodium 4-chlorophenylthiomethylenebisphosphonate monohydrate. This invention relates to the compound itself, as well as the method of preparing this monohydrate. Additionally, it encompasses pharmaceutical compositions where disodium tiludronate monohydrate serves as the active principle. Another patent involves disodium 4-chlorophenylmethylenebisphosphonate monohydrate, which also details a method for its preparation and its use in pharmaceutical compositions.
Career Highlights
Michel Bonnery is associated with Sanofi, a leading global healthcare company. His work at Sanofi has allowed him to focus on the development of innovative pharmaceutical solutions that address various health challenges.
Collaborations
Bonnery has collaborated with notable colleagues, including Michel Bouisset and Raphael Sole. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Michel Bonnery is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable innovations. His contributions continue to impact the field positively, showcasing the importance of research and development in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile